Nuclear envelope invaginations and cancer

Advances in Experimental Medicine and Biology

Volumn 773, Issue , 2014, Pages 523-535

  Malhas, Ashraf N ^a   Vaux, David J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Gene expression; Nuclear envelope; Nuclear invaginations; Nucleoplasmic reticulum

Indexed keywords

EMERIN; LAMIN A; LAMIN B; LAMIN C;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER DIAGNOSIS; CANCER PROGNOSIS; CARCINOGENESIS; CELL CYCLE REGULATION; CELL NUCLEUS MEMBRANE; CELL ORGANELLE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN STRUCTURE; CHROMOSOME TRANSLOCATION; CYTOSKELETON; HUMAN; LAMINOPATHY; METASTASIS; NONHUMAN; NUCLEAR ENVELOPE INVAGINATION; NUCLEAR SHAPE; NUCLEAR SIZE; NUCLEOPLASMIC RETICULUM; ONCOGENE RET; PRIORITY JOURNAL; PROSTATE CANCER; THYROID PAPILLARY CARCINOMA;

CELL TRANSFORMATION, NEOPLASTIC; HUMANS; NEOPLASMS; NUCLEAR ENVELOPE; PROGNOSIS;

EID: 84934442489     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4899-8032-8_24     Document Type: Article

References (80)

1. Prunuske AJ, Ullman KS (2006) The nuclear envelope: form and reformation. Curr Opin Cell Biol 18(1):108-116. doi: 10.1016/j.ceb.2005.12.004 , S0955-0674(05)00185-7 [pii]
2. Dauer WT, Worman HJ (2009) The nuclear envelope as a signaling node in development and disease. Dev Cell 17(5):626-638. doi: 10.1016/j.devcel.2009.10. 016 , S1534-5807(09)00438-9 [pii]
3. Mekhail K, Moazed D (2010) The nuclear envelope in genome organization, expression and stability. Nat Rev Mol Cell Biol 11(5):317-328. doi: 10.1038/nrm2894 , nrm2894 [pii]
4. Redwood AB, Perkins SM, Vanderwaal RP, Feng Z, Biehl KJ, Gonzalez-Suarez I, Morgado-Palacin L, Shi W, Sage J, Roti-Roti JL, Stewart CL, Zhang J, Gonzalo S (2011) A dual role for A-type lamins in DNA double-strand break repair. Cell Cycle 10(15):2549-2560. doi: 1 6531 [pii]
5. Worman HJ (2012) Nuclear lamins and laminopathies. J Pathol 226(2):316-325. doi: 10.1002/path.2999
6. Broers JL, Ramaekers FC, Bonne G, Yaou RB, Hutchison CJ (2006) Nuclear lamins: laminopathies and their role in premature ageing. Physiol Rev 86(3):967-1008. doi: 10.1152/physrev. 00047.2005 , 86/3/967 [pii]
7. Kamei H (1994) Relationship of nuclear invaginations to perinuclear rings composed of intermediate fi laments in MIA PaCa-2 and some other cells. Cell Struct Funct 19(3):123-132
8. Fricker M, Hollinshead M, White N, Vaux D (1997) The convoluted nucleus. Trends Cell Biol 7(5):181. doi: S0962-8924(97)84084-6 , [pii]10.1016/S0962- 8924(97)84084-6
9. Fricker M, Hollinshead M, White N, Vaux D (1997) Interphase nuclei of many mammalian cell types contain deep, dynamic, tubular membrane-bound invaginations of the nuclear envelope. J Cell Biol 136(3):531-544
10. Schermelleh L, Carlton PM, Haase S, Shao L, Winoto L, Kner P, Burke B, Cardoso MC, Agard DA, Gustafsson MG, Leonhardt H, Sedat JW (2008) Subdiffraction multicolor imaging of the nuclear periphery with 3D structured illumination microscopy. Science 320(5881):1332-1336. doi: 10.1126/science.1156947 , 320/5881/1332 [pii]
11. Clubb BH, Locke M (1998) 3T3 cells have nuclear invaginations containing F-actin. Tissue Cell 30(6):684-691
12. Brandes D, Schofi eld BH, Anton E (1965) Nuclear mitochondria? Science 149(3690):1373-1374
13. Malhas A, Goulbourne C, Vaux DJ (2011) The nucleoplasmic reticulum: form and function. Trends Cell Biol 21(6):362-373. doi: 10.1016/j.tcb.2011.03.008 , S0962-8924(11)00050-X [pii]
14. True LD, Jordan CD (2008) The cancer nuclear microenvironment: interface between light microscopic cytology and molecular phenotype. J Cell Biochem 104(6):1994-2003. doi: 10.1002/jcb.21478
15. Gupton SL, Collings DA, Allen NS (2006) Endoplasmic reticulum targeted GFP reveals ER organization in tobacco NT-1 cells during cell division. Plant Physiol Biochem 44(2-3): 95-105. doi: 10.1016/j.plaphy.2006.03.003 , S0981-9428(06)00033-7 [pii]
16. Fischer AH, Taysavang P, Jhiang SM (2003) Nuclear envelope irregularity is induced by RET/PTC during interphase. Am J Pathol 163(3):1091-1100. doi: 10.1016/S0002-9440(10)63468-2 , S0002-9440(10)63468-2 [pii]
17. Bootman MD, Fearnley C, Smyrnias I, MacDonald F, Roderick HL (2009) An update on nuclear calcium signalling. J Cell Sci 122(Pt 14):2337-2350. doi: 10.1242/jcs.028100 , 122/14/2337 [pii]
18. Chow KH, Factor RE, Ullman KS (2012) The nuclear envelope environment and its cancer connections. Nat Rev Cancer 12(3):196-209. doi: 10.1038/nrc3219 , nrc3219 [pii]
19. Mounkes L, Kozlov S, Burke B, Stewart CL (2003) The laminopathies: nuclear structure meets disease. Curr Opin Genet Dev 13(3):223-230, S0959437X03000583 [pii]
20. McClintock D, Gordon LB, Djabali K (2006) Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody. Proc Natl Acad Sci USA 103(7):2154-2159. doi: 10.1073/pnas.0511133103 , 0511133103 [pii]
21. De Sandre-Giovannoli A, Bernard R, Cau P, Navarro C, Amiel J, Boccaccio I, Lyonnet S, Stewart CL, Munnich A, Le Merrer M, Levy N (2003) Lamin a truncation in Hutchinson-Gilford progeria. Science 300(5628):2055. doi: 10.1126/science.1084125 , 1084125 [pii]
22. Scaffi di P, Misteli T (2006) Lamin A-dependent nuclear defects in human aging. Science 312(5776):1059-1063. doi: 10.1126/science.1127168 , 1127168 [pii]
23. Tang Y, Chen Y, Jiang H, Nie D (2010) Promotion of tumor development in prostate cancer by progerin. Cancer Cell Int 10:47. doi: 10.1186/1475-2867-10-47 , 1475-2867-10-47 [pii]
24. Zink D, Fischer AH, Nickerson JA (2004) Nuclear structure in cancer cells. Nat Rev Cancer 4(9):677-687. doi: 10.1038/nrc1430 , nrc1430 [pii]
25. Bussolati G, Marchio C, Gaetano L, Lupo R, Sapino A (2008) Pleomorphism of the nuclear envelope in breast cancer: a new approach to an old problem. J Cell Mol Med 12(1):209-218. doi: 10.1111/j.1582-4934.2007.00176.x , JCMM176 [pii]
26. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19(5):403-410
27. Boyd J, Pienta KJ, Getzenberg RH, Coffey DS, Barrett JC (1991) Preneoplastic alterations in nuclear morphology that accompany loss of tumor suppressor phenotype. J Natl Cancer Inst 83(12):862-866
28. Bloom HJ, Richardson WW (1957) Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11(3): 359-377
29. Giardina C, Caniglia DM, D'Aprile M, Lettini T, Serio G, Cipriani T, Ricco R, Pesce Delfino V (1996) Nuclear morphometry in squamous cell carcinoma (SCC) of the tongue. Eur J Cancer B Oral Oncol 32B(2):91-96
30. Nativ O, Sabo E, Bejar J, Halachmi S, Moskovitz B, Miselevich I (1996) A comparison between histological grade and nuclear morphometry for predicting the clinical outcome of localized renal cell carcinoma. Br J Urol 78(1):33-38
31. Partin AW, Gearhart JP, Leonard MP, Leventhal BG, Yoo JK, Crooks D, Epstein JI, Beckwith JB (1993) The use of nuclear morphometry to predict prognosis in pediatric urologic malignancies: a review. Med Pediatr Oncol 21(3):222-229
32. Epstein JI, Berry SJ, Eggleston JC (1984) Nuclear roundness factor. A predictor of progression in untreated Stage A2 prostate cancer. Cancer 54(8):1666-1671
33. Mohler JL, Figlesthaler WM, Zhang XZ, Partin AW, Maygarden SJ (1994) Nuclear shape analysis for the assessment of local invasion and metastases in clinically localized prostate carcinoma. Cancer 74(11):2996-3001
34. Partin AW, Steinberg GD, Pitcock RV, Wu L, Piantadosi S, Coffey DS, Epstein JI (1992) Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict diseasefree survival among patients with prostate cancer. Cancer 70(1):161-168
35. Liu CQ, Sasaki H, Fahey MT, Sakamoto A, Sato S, Tanaka T (1999) Prognostic value of nuclear morphometry in patients with TNM stage T1 ovarian clear cell adenocarcinoma. Br J Cancer 79(11-12):1736-1741. doi: 10.1038/sj.bjc.6690276
36. Asioli S, Bussolati G (2009) Emerin immunohistochemistry reveals diagnostic features of nuclear membrane arrangement in thyroid lesions. Histopathology 54(5):571-579. doi: 10.1111/j.1365-2559.2009.03259.x , HIS3259 [pii]
37. Asioli S, Maletta F, Pacchioni D, Lupo R, Bussolati G (2010) Cytological detection of papillary thyroid carcinomas by nuclear membrane decoration with emerin staining. Virchows Arch 457(1):43-51. doi: 10.1007/s00428-010-0910-z
38. Batistatou A, Scopa CD (2009) Pathogenesis and diagnostic signifi cance of nuclear grooves in thyroid and other sites. Int J Surg Pathol 17(2):107-110. doi: 10.1177/1066896908316071 , 1066896908316071 [pii]
39. Bussolati G (2008) Proper detection of the nuclear shape: ways and signifi cance. Rom J Morphol Embryol 49(4):435-439, 490408435439 [pii]
40. Elisei R, Romei C, Vorontsova T, Cosci B, Veremeychik V, Kuchinskaya E, Basolo F, Demidchik EP, Miccoli P, Pinchera A, Pacini F (2001) RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. J Clin Endocrinol Metab 86(7):3211-3216
41. Pisarchik AV, Ermak G, Fomicheva V, Kartel NA, Figge J (1998) The ret/PTC1 rearrangement is a common feature of Chernobyl-associated papillary thyroid carcinomas from Belarus. Thyroid 8(2):133-139
42. Santoro M, Sabino N, Ishizaka Y, Ushijima T, Carlomagno F, Cerrato A, Grieco M, Battaglia C, Martelli ML, Paulin C et al (1993) Involvement of RET oncogene in human tumours: specifi city of RET activation to thyroid tumours. Br J Cancer 68(3):460-464
43. Fischer AH, Bond JA, Taysavang P, Battles OE, Wynford-Thomas D (1998) Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure. Am J Pathol 153(5):1443-1450. doi: 10.1016/S0002-9440(10) 65731-8 , S0002-9440(10)65731-8 [pii]
44. Wynford-Thomas D (1997) Origin and progression of thyroid epithelial tumours: cellular and molecular mechanisms. Horm Res 47(4-6):145-157
45. Fischer AH, Taysavang P, Weber CJ, Wilson KL (2001) Nuclear envelope organization in papillary thyroid carcinoma. Histol Histopathol 16(1):1-14
46. Franke WW, Schinko W (1969) Nuclear shape in muscle cells. J Cell Biol 42(1):326-331
47. Lane BP (1965) Alterations in the cytologic detail of intestinal smooth muscle cells in various stages of contraction. J Cell Biol 27(1):199-213
48. Dey P (2010) Cancer nucleus: morphology and beyond. Diagn Cytopathol 38(5):382-390. doi: 10.1002/dc.21234
49. Luo RX, Postigo AA, Dean DC (1998) Rb interacts with histone deacetylase to repress transcription. Cell 92(4):463-473, S0092-8674(00)80940-X [pii]
50. Robertson KD, Ait-Si-Ali S, Yokochi T, Wade PA, Jones PL, Wolffe AP (2000) DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat Genet 25(3):338-342. doi: 10.1038/77124
51. Nielsen SJ, Schneider R, Bauer UM, Bannister AJ, Morrison A, O'Carroll D, Firestein R, Cleary M, Jenuwein T, Herrera RE, Kouzarides T (2001) Rb targets histone H3 methylation and HP1 to promoters. Nature 412(6846):561-565. doi: 10.1038/35087620 , 35087620 [pii]
52. Vandel L, Nicolas E, Vaute O, Ferreira R, Ait-Si-Ali S, Trouche D (2001) Transcriptional repression by the retinoblastoma protein through the recruitment of a histone methyltransferase. Mol Cell Biol 21(19):6484-6494
53. Marshall WF (2002) Order and disorder in the nucleus. Curr Biol 12(5):R185-R192, S0960982202007248 [pii]
54. Pickersgill H, Kalverda B, de Wit E, Talhout W, Fornerod M, van Steensel B (2006) Characterization of the Drosophila melanogaster genome at the nuclear lamina. Nat Genet 38(9):1005-1014. doi: 10.1038/ng1852 , ng1852 [pii]
55. Guelen L, Pagie L, Brasset E, Meuleman W, Faza MB, Talhout W, Eussen BH, de Klein A, Wessels L, de Laat W, van Steensel B (2008) Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions. Nature 453(7197):948-951. doi: 10.1038/nature06947 , nature06947 [pii]
56. Parada L, Misteli T (2002) Chromosome positioning in the interphase nucleus. Trends Cell Biol 12(9):425-432, S0962892402023516 [pii]
57. Cremer T, Cremer M, Dietzel S, Muller S, Solovei I, Fakan S (2006) Chromosome territories- A functional nuclear landscape. Curr Opin Cell Biol 18(3):307-316. doi: 10.1016/j. ceb.2006.04.007 , S0955-0674(06)00056-1 [pii]
58. Gandhi MS, Stringer JR, Nikiforova MN, Medvedovic M, Nikiforov YE (2009) Gene position within chromosome territories correlates with their involvement in distinct rearrangement types in thyroid cancer cells. Genes Chromosomes Cancer 48(3):222-228. doi: 10.1002/gcc.20639
59. Heng HH, Goetze S, Ye CJ, Liu G, Stevens JB, Bremer SW, Wykes SM, Bode J, Krawetz SA (2004) Chromatin loops are selectively anchored using scaffold/matrix-attachment regions. J Cell Sci 117(Pt 7):999-1008. doi: 10.1242/jcs.00976 , 117/7/999 [pii]
60. Cai S, Han HJ, Kohwi-Shigematsu T (2003) Tissue-specifi c nuclear architecture and gene expression regulated by SATB1. Nat Genet 34(1):42-51. doi: 10.1038/ng1146 ng1146 [pii]
61. Schwartz GH, Patnaik A, Hammond LA, Rizzo J, Berg K, Von Hoff DD, Rowinsky EK (2003) A phase I study of bizelesin, a highly potent and selective DNA-interactive agent, in patients with advanced solid malignancies. Ann Oncol 14(5):775-782
62. Goulbourne CN, Malhas AN, Vaux DJ (2011). The induction of a nucleoplasmic reticulum by prelamin A accumulation requires CTP:phosphocholine cytidylyltransferase-alpha. J Cell Sci 124 (Pt 24):4253-4266. doi:jcs.091009 [pii]10.1242/jcs.091009
63. Leighl NB, Dent S, Clemons M, Vandenberg TA, Tozer R, Warr DG, Crump RM, Hedley D, Pond GR, Dancey JE, Moore MJ (2008) A Phase 2 study of perifosine in advanced or metastatic breast cancer. Breast Cancer Res Treat 108(1):87-92. doi: 10.1007/s10549-007-9584-x
64. Su JS, Woods SM, Ronen SM (2012) Metabolic consequences of treatment with AKT inhibitor perifosine in breast cancer cells. NMR Biomed 25(2):379-388. doi: 10.1002/nbm.1764
65. Helfand BT, Wang Y, Pfl eghaar K, Shimi T, Taimen P, Shumaker DK (2012) Chromosomal regions associated with prostate cancer risk localize to lamin B-defi cient microdomains and exhibit reduced gene transcription. J Pathol 226(5):735-745. doi: 10.1002/path.3033
66. Helfand BT, Loeb S, Cashy J, Meeks JJ, Thaxton CS, Han M, Catalona WJ (2008) Tumor characteristics of carriers and noncarriers of the deCODE 8q24 prostate cancer susceptibility alleles. J Urol 179(6):2197-2201. doi: 10.1016/j.juro.2008.01.110 , discussion 2202. S0022-5347(08)00257-7 [pii]
67. Staebler A, Karberg B, Behm J, Kuhlmann P, Neubert U, Schmidt H, Korsching E, Burger H, Lelle R, Kiesel L, Bocker W, Shih Ie M, Buchweitz O (2006) Chromosomal losses of regions on 5q and lack of high-level amplifi cations at 8q24 are associated with favorable prognosis for ovarian serous carcinoma. Genes Chromosomes Cancer 45(10):905-917. doi: 10.1002/gcc.20356
68. Hewitt SL, High FA, Reiner SL, Fisher AG, Merkenschlager M (2004) Nuclear repositioning marks the selective exclusion of lineage-inappropriate transcription factor loci during T helper cell differentiation. Eur J Immunol 34(12):3604-3613. doi: 10.1002/eji.200425469
69. Chuang CH, Carpenter AE, Fuchsova B, Johnson T, de Lanerolle P, Belmont AS (2006) Longrange directional movement of an interphase chromosome site. Curr Biol 16(8):825-831. doi: 10.1016/j.cub.2006.03.059 , S0960-9822(06)01356-X [pii]
70. Malhas A, Lee CF, Sanders R, Saunders NJ, Vaux DJ (2007) Defects in lamin B1 expression or processing affect interphase chromosome position and gene expression. J Cell Biol 176(5):593-603. doi: 10.1083/jcb.200607054 , jcb.200607054 [pii]
71. Ruault M, Dubarry M, Taddei A (2008) Re-positioning genes to the nuclear envelope in mammalian cells: impact on transcription. Trends Genet 24(11):574-581. doi: 10.1016/j. tig.2008.08.008 , S0168-9525(08)00228-X [pii]
72. Heessen S, Fornerod M (2007) The inner nuclear envelope as a transcription factor resting place. EMBO Rep 8(10):914-919. doi: 10.1038/sj.embor.7401075 , 7401075 [pii]
73. Gonzalez JM, Navarro-Puche A, Casar B, Crespo P, Andres V (2008) Fast regulation of AP-1 activity through interaction of lamin A/C, ERK1/2, and c-Fos at the nuclear envelope. J Cell Biol 183(4):653-666. doi: 10.1083/jcb.200805049 , jcb.200805049 [pii]
74. Malhas AN, Lee CF, Vaux DJ (2009) Lamin B1 controls oxidative stress responses via Oct-1. J Cell Biol 184(1):45-55. doi: 10.1083/jcb.200804155 , jcb.200804155 [pii]
75. Malhas A, Saunders NJ, Vaux DJ (2010) The nuclear envelope can control gene expression and cell cycle progression via miRNA regulation. Cell Cycle 9(3):531-539, 10511 [pii]
76. Bandres E, Cubedo E, Agirre X, Malumbres R, Zarate R, Ramirez N, Abajo A, Navarro A, Moreno I, Monzo M, Garcia-Foncillas J (2006) Identifi cation by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 5:29. doi: 10.1186/1476-4598-5-29 , 1476-4598-5-29 [pii]
77. Slaby O, Svoboda M, Fabian P, Smerdova T, Knofl ickova D, Bednarikova M, Nenutil R, Vyzula R (2007) Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 72(5-6):397-402. doi: 10.1159/000113489 , 000113489 [pii]
78. Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szasz AM, Wang ZC, Brock JE, Richardson AL, Weinberg RA (2009) A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137(6):1032-1046. doi: 10.1016/j.cell.2009.03.047 , S0092-8674(09)00390-0 [pii]
79. Valastyan S, Chang A, Benaich N, Reinhardt F, Weinberg RA (2011) Activation of miR-31 function in already-established metastases elicits metastatic regression. Genes Dev 25(6): 646-659. doi: 10.1101/gad.2004211 , 25/6/646 [pii]
80. Szafranska AE, Davison TS, John J, Cannon T, Sipos B, Maghnouj A, Labourier E, Hahn SA (2007) MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 26(30):4442-4452. doi: 10.1038/sj. onc.1210228 , 1210228 [pii]